Bioliberty, a Scottish healthtech startup based in Edinburgh and Boston, raised $10.2 million to build functional intelligence capabilities for post-acute care.
The funding aligns with prior Series A investment of £6.2M (approximately $8M USD), including £3M from the Scottish National Investment Bank.
Bioliberty focuses on recovery from mobility-limiting conditions using innovative medical devices, such as air-powered technology.
The news appeared in recent headlines on March 19, 2026, alongside Boston health updates.